GE's Record Volume Surge Propels 421st-Ranked Stock Amid Analyst and Institutional Divide

On September 2, 2025, General Electric (GE) recorded a trading volume of $260 million, a 75.66% increase from the previous day, ranking 421st in the market. GE HealthCare (GEHC) fell 2.89% during the session.

Institutional investors have shown mixed activity in GEHC. The Manufacturers Life Insurance Company increased its stake by 1.2% in Q1, holding 982,765 shares valued at $79.3 million. Bessemer Group Inc. and Farther Finance Advisors LLC also raised their holdings by 24.3% and 52.7%, respectively. Conversely, Armistice Capital LLC reduced its position by 23.1%, selling 91,251 shares. Institutional ownership accounts for 82.06% of the stock.

Analyst sentiment remains divided. Citigroup upgraded GEHC to "buy" with a $93 price target, while Morgan Stanley cut its target to $74 and assigned "equal weight." UBS Group moved from "sell" to "neutral," lowering its target to $73. Wall Street Zen raised its rating to "buy." The stock has an average "Moderate Buy" rating with a $88.55 consensus target.

GEHC reported Q2 earnings of $1.06 per share, exceeding estimates of $0.91, and revenue of $5 billion, a 3.5% year-over-year increase. The company also declared a $0.035 quarterly dividend, yielding 0.2% annually. With a P/E ratio of 15.11 and a 3.5% revenue growth, the stock remains underpinned by strong operational performance.

Backtest results show GEHC lagging the S&P 500 in multi-year returns. The stock delivered a 13.65% total return over five years, compared to the S&P 500’s 79.16%. Year-to-date, GEHC returned 8.29%, trailing the index’s 9.08%. Over one year, the stock gained 15.44% versus the S&P 500’s 13.58%.